OpenAlex
PricingAboutJobs
Log inGet started
Work

A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia

HTML

Year: 2008
Type: article
Study design: Clinical Trial
Source: European Journal Of Haematology
DOI: 10.1111/j.1600-0609.2008.01102.x
Authors: Peter Gimsing, Mads Hansen, Lene M. Knudsen, P. Knoblauch, Ib Jarle Christensen, Chean Eng Ooi, Peter Buhl‐Jensen
Institutions: Copenhagen University Hospital, Rigshospitalet, Herlev Hospital
Language: English

Topic: Histone Deacetylase Inhibitors Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: belinostat, histone deacetylase inhibitors, hydroxamate, multiple myeloma, diffuse large cell lymphoma, chronic lymphocytic leukemia, dose-limiting toxicity, maximum tolerated dose, renal failure, tumor lysis syndrome, drug safety, stable disease, status epilepticus, lymphopenia, fatigue, nausea and vomiting
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1991376723
FWCI: 6.278
Cites: 25
Cited by: 170
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security